ChromaDex (NASDAQ:CDXC) Releases Earnings Results

by · The Cerbat Gem

ChromaDex (NASDAQ:CDXC – Get Free Report) released its earnings results on Thursday. The company reported $0.02 earnings per share for the quarter, Zacks reports. ChromaDex had a return on equity of 5.06% and a net margin of 1.62%. The business had revenue of $25.58 million for the quarter, compared to analyst estimates of $23.70 million. During the same quarter last year, the firm posted ($0.01) earnings per share. ChromaDex updated its FY 2024 guidance to EPS.

ChromaDex Trading Up 67.9 %

Shares of ChromaDex stock traded up $2.37 during trading hours on Friday, reaching $5.86. The stock had a trading volume of 37,543,352 shares, compared to its average volume of 264,220. The firm has a market capitalization of $444.95 million, a PE ratio of 586.59 and a beta of 1.88. The stock’s 50 day moving average is $3.53 and its 200 day moving average is $3.23. ChromaDex has a twelve month low of $1.32 and a twelve month high of $5.98.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reaffirmed a “buy” rating and set a $6.00 target price on shares of ChromaDex in a research report on Friday, August 9th.

Get Our Latest Stock Report on ChromaDex

Insider Buying and Selling

In other news, Director Kristin Patrick sold 23,000 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $3.57, for a total transaction of $82,110.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 9.64% of the company’s stock.

ChromaDex Company Profile

(Get Free Report)

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products.

Further Reading